Beximco Pharmaceuticals Limited Share Price London S.E.

Equities

BXP

US0885792061

Pharmaceuticals

Market Closed - London S.E. 16:35:06 28/06/2024 BST 5-day change 1st Jan Change
39 GBX -.--% Intraday chart for Beximco Pharmaceuticals Limited -1.27% -6.02%

Financials

Sales 2024 * 44.51B 379M 29.95B Sales 2025 * 50.42B 429M 33.93B Capitalization 52.69B 448M 35.46B
Net income 2024 * 5.25B 44.7M 3.53B Net income 2025 * 6.24B 53.15M 4.2B EV / Sales 2024 * 1.32 x
Net Debt 2024 * 5.96B 50.7M 4.01B Net Debt 2025 * 878M 7.48M 591M EV / Sales 2025 * 1.06 x
P/E ratio 2024 *
9.6 x
P/E ratio 2025 *
7.82 x
Employees 5,700
Yield 2024 *
3.52%
Yield 2025 *
4.45%
Free-Float 76.68%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.27%
1 month+1.30%
6 months-6.02%
Current year-6.02%
More quotes
1 week
38.20
Extreme 38.2
40.00
1 month
37.15
Extreme 37.15
40.00
Current year
33.56
Extreme 33.555
42.00
1 year
33.56
Extreme 33.555
45.00
3 years
33.30
Extreme 33.3
131.00
5 years
28.07
Extreme 28.0695
131.00
10 years
10.10
Extreme 10.1009
131.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 61 31/12/89
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Founder - 31/12/75
Founder - 31/12/75
Chief Executive Officer - 31/12/84
More insiders
Date Price Change Volume
28/06/24 39 -.--% 10,000
27/06/24 39 -.--% 5,662
26/06/24 39 -1.27% 60,046
25/06/24 39.5 -.--% 48,800
24/06/24 39.5 -.--% 92,167

Delayed Quote London S.E., June 28, 2024 at 04:35 pm

More quotes
Beximco Pharmaceuticals Limited is a Bangladesh-based company which is a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. It offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
118.1 BDT
Average target price
177.5 BDT
Spread / Average Target
+50.30%
Consensus

Annual profits - Rate of surprise